Literature DB >> 15056980

Bartter's and Gitelman's syndromes: from gene to clinic.

Maarten Naesens1, Paul Steels, René Verberckmoes, Yves Vanrenterghem, Dirk Kuypers.   

Abstract

Bartter's and Gitelman's syndromes are characterized by hypokalemia, normal to low blood pressure and hypochloremic metabolic alkalosis. Recently, investigators have been able to demonstrate mutations of six genes encoding several renal tubular transporters and ion channels that can be held responsible for Bartter's and Gitelman's syndromes. Neonatal Bartter's syndrome is caused by mutations of NKCC2 or ROMK, classic Bartter's syndrome by mutations of ClC-Kb, Bartter's syndrome associated with sensorineural deafness is due to mutations of BSND, Gitelman's syndrome to mutations of NCCT and Bartter's syndrome associated with autosomal dominant hypocalcemia is linked to mutations of CASR. We review the pathophysiology of these syndromes in relation to their clinical presentation. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056980     DOI: 10.1159/000076752

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  44 in total

Review 1.  Gitelman's syndrome: a pathophysiological and clinical update.

Authors:  Farid Nakhoul; Nakhoul Nakhoul; Evgenia Dorman; Liron Berger; Karl Skorecki; Daniella Magen
Journal:  Endocrine       Date:  2011-11-15       Impact factor: 3.633

Review 2.  Pivotal role of the kidney in hypertension.

Authors:  L Lee Hamm; Kathleen S Hering-Smith
Journal:  Am J Med Sci       Date:  2010-07       Impact factor: 2.378

3.  A compound heterozygous mutation in the BSND gene detected in Bartter syndrome type IV.

Authors:  Sachiko Kitanaka; Utako Sato; Kenichi Maruyama; Takashi Igarashi
Journal:  Pediatr Nephrol       Date:  2005-12-03       Impact factor: 3.714

Review 4.  Kidney stone disease.

Authors:  Fredric L Coe; Andrew Evan; Elaine Worcester
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 5.  Trafficking to the apical and basolateral membranes in polarized epithelial cells.

Authors:  Emily H Stoops; Michael J Caplan
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

Review 6.  The Peroxisome Proliferator-Activated Receptor-Gamma Coactivator-1α-Heme Oxygenase 1 Axis, a Powerful Antioxidative Pathway with Potential to Attenuate Diabetic Cardiomyopathy.

Authors:  Maayan Waldman; Michael Arad; Nader G Abraham; Edith Hochhauser
Journal:  Antioxid Redox Signal       Date:  2020-03-25       Impact factor: 8.401

Review 7.  Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension.

Authors:  Verdiana Ravarotto; Elisa Pagnin; Antonio Fragasso; Giuseppe Maiolino; Lorenzo A Calò
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-03-11

Review 8.  Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes.

Authors:  L A Calò; G Maiolino
Journal:  J Endocrinol Invest       Date:  2015-03-05       Impact factor: 4.256

9.  High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?

Authors:  L A Calò; R Montisci; R Scognamiglio; P A Davis; E Pagnin; S Schiavo; P Mormino; A Semplicini; P Palatini; A D'Angelo; A C Pessina
Journal:  J Endocrinol Invest       Date:  2009-07-14       Impact factor: 4.256

10.  Gitelman or Bartter type 3 syndrome? A case of distal convoluted tubulopathy caused by CLCNKB gene mutation.

Authors:  António José Cruz; Alexandra Castro
Journal:  BMJ Case Rep       Date:  2013-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.